Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

PDSB PDS Biotechnology Corporation

0.1898 (6.98%)
After Hours
Last Updated: 18:05:18
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
PDS Biotechnology Corporation PDSB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.1898 6.98% 2.9098 18:05:18
Open Price Low Price High Price Close Price Prev Close
2.72 2.69 3.015 2.90 2.72
more quote information »

Recent News

Date Time Source Heading
1/23/202416:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/23/202416:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/22/202417:10EDGAR2Form 8-K - Current report
1/22/202416:45GLOBEPDS Biotech Announces Retirement of Lauren V. Wood, M.D.,..
1/16/202408:00GLOBEPDS Biotech to Participate at B. Riley Securities 4th Annual..
12/04/202316:50GLOBEPDS Biotechnology Reports Inducement Grant Under Nasdaq..
12/04/202316:02EDGAR2Form 8-K - Current report
11/28/202307:30GLOBEPDS Biotech Appoints Lars Boesgaard as Chief Financial..
11/28/202306:02EDGAR2Form 8-K - Current report
11/14/202307:30GLOBEPDS Biotech Reports Third Quarter 2023 Financial Results and..
11/09/202316:07EDGAR2Form 8-K - Current report
11/09/202308:00GLOBEPDS Biotech Announces Updated Survival Data from NCI-Led..
11/07/202308:00GLOBEPDS Biotechnology Announces Conference Call and Webcast for..
10/23/202316:06EDGAR2Form 8-K - Current report
10/23/202308:00GLOBEPDS Biotech Announces Preliminary Biomarker Study Results in..
10/11/202316:02EDGAR2Form 8-K - Current report
10/11/202308:00GLOBEPDS Biotech Announces Interim Safety and Immune Response..
10/03/202316:03EDGAR2Form 8-K - Current report
10/03/202316:03EDGAR2Form 8-K - Current report
10/03/202309:02EDGAR2Form 8-K - Current report
10/03/202307:00GLOBEPDS Biotech Announces Interim 24-Month Survival Rate of 74%..
10/02/202316:05EDGAR2Form 8-K - Current report
10/02/202308:00GLOBEPDS Biotech Announces PDS0101 Combined with..
9/26/202308:00GLOBEPDS Biotech to Present at the LD Micro Main Event XVI
9/25/202308:00GLOBEPDS Biotech Reschedules Key Opinion Leader Roundtable..
9/20/202316:10EDGAR2Form 8-K - Current report
9/20/202316:05GLOBEPDS Biotech to Participate in the 2023 Cantor Fitzgerald..
9/20/202308:00GLOBEPDS Biotech Announces PDS0202 Elicits Active Neutralization..
9/13/202308:00GLOBEPDS Biotech to Host Key Opinion Leader Roundtable Addressing..
9/11/202316:05EDGAR2Form 8-K - Current report
9/08/202306:02EDGAR2Form 8-K - Current report
9/06/202316:05GLOBEPDS Biotech to Participate at the H.C. Wainwright 25th..
9/06/202308:00GLOBEPDS0202 Universal Influenza Preclinical Ferret Data to be..
8/18/202316:04EDGAR2Form 8-K - Current report
8/17/202316:05EDGAR2Form 8-K - Current report
8/16/202308:00GLOBEPDS Biotech Announces Data from IMMUNOCERV Phase 2 Trial..
8/14/202316:05EDGAR2Form 8-K - Current report
8/14/202313:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202307:30GLOBEPDS Biotech Reports Second Quarter 2023 Financial Results..
8/14/202307:00GLOBEPDS Biotech Announces Submission of Phase 3 Protocol to FDA..
8/07/202308:00GLOBEPDS Biotechnology Announces Conference Call and Webcast for..
8/02/202308:00GLOBEPDS Biotech to Present at BTIG Virtual Biotechnology..
7/25/202316:01EDGAR2Form 8-K - Current report
7/25/202308:00GLOBEPDS Biotech to Present Immune Response Data from Combination..
7/17/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/17/202317:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/17/202317:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/17/202317:24EDGAR2Form 8-K - Current report
7/17/202317:23EDGAR2Form 8-K - Current report
7/17/202308:00GLOBEPDS Biotech Announces Acceptance of Abstract on Combination..

Your Recent History

Delayed Upgrade Clock